AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Etonogestrel Implant as Emergency Contraception

RecruitingPhase 4Ages 18 Years - 40 YearsFemaleUniversity of Colorado, Denver
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The investigators propose a single site, single arm, open label mechanism of action pharmacodynamic pilot study of etonogestrel implant insertion prior to an luteinizing hormone (LH) surge. The investigators will evaluate ovulation rates via serum levels of reproductive hormones and transvaginal ultrasound findings following placement of an etonogestrel implant once the dominant follicle reaches a size of 15mm or greater, but prior to an LH surge, in persons with prior documented regular cycles and confirmed ovulation. The researchers' hypothesis is that ovulation will be inhibited if the etonogestrel implant is placed prior to an LH surge. Based on data from the Food and Drug Administration label for Nexplanon, etonogestrel rises to levels associated with ovulation suppression within 8 hours of placement. Given this rapid increase, it is therefore plausible to assume that ovulation can

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * BMI less than or equal to 28kg/m2 * Intact uterus with at least one ovary * Regular menstrual cycles that occur every 21-35 days * If patient is postpartum or post-second trimester abortion, 3 menses (2 cycles) must have occurred prior to enrollment * If patient had a first trimester abortion or pregnancy loss, she must have one spontaneous menses prior to enrollment * Desires insertion of an etonogestrel contraceptive implant for contraception * Not currently pregnant or trying to become pregnant * Willing to abstain from medications and supplements known to induce/inhibit CYP3A4 during the study Exclusion Criteria: * Have a known hypersensitivity or contraindications to etonogestrel. * Medical conditions that affect liver function (e.g., hepatitis, cirrhosis; assessed via participant self-report) * Known or suspected current alcohol dependence syndrome or any illicit drug use that may affect the metabolism of the etonogestrel. * Uncontrolled thyroid disorder. * Use of long-acting injectable hormonal contraceptive within the past 9 months * Current use of hormonal oral, patch, intravaginal, or intrauterine contraception
๐Ÿ’Š

What it tests

  • Etonogestrel implant
๐Ÿ“

Where

1 site
University of Colorado Denver
Aurora, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy